Profile picture

Professor Wolfgang Koenig

Technical University of Munich, Munich (Germany)
Membership: FESC Member
Follow
Biography
Wolfgang Koenig, MD, FRCP, FACC, FAHA, FESC is a Professor of Cardiology. A former Director of the WHO-MONICA Augsburg Myocardial Infarction Registry, he has held multiple clinical positions at the University of Ulm Medical Center. In April 2015 he joined the Deutsches Herzzentrum München, where he is the Head of the Cardiometabolic Unit. Professor Koenig serves on the steering committee of multiple large clinical trials. His research also includes the molecular basis of atherothrombogenesis, and focuses on the identification and evaluation of new biomarkers for cardiometabolic diseases. He has published more than 900 papers in peer-reviewed journals. Between 2008–2017, he ranked sixtieth among the most frequently cited German speaking researchers in cardiovascular disease and has an H-Index of 101. He is a member of the Editorial Board of “Clinical Chemistry”. In 2020 he received the Paul-Morawitz-Award from the German Cardiac Society.
Logo ESC

Contributor content

Lipids and myocardial infarction
Session
Lipids and myocardial infarction
31 August 2026
Lipid lowering and cardiovascular outcomes
Session
Lipid lowering and cardiovascular outcomes
30 August 2026
Innovations in post-infarction care: cardiometabolic, molecular, and haemodynamic approaches
Session
Innovations in post-infarction care: cardiometabolic, molecular, and haemodynamic approaches
30 August 2026
Therapeutic advancements in lipid-lowering pharmacotherapy
Session
Therapeutic advancements in lipid-lowering pharmacotherapy
29 August 2026
Epidemiology, prognosis, and outcome in acute coronary syndromes: artificial intelligence, sex differences, and socioeconomic impact
Session
Epidemiology, prognosis, and outcome in acute coronary syndromes: artificial intelligence, sex differences, and socioeconomic impact
29 August 2026
Cooling the fire of cardiovascular inflammation: what are the treatment options in 2026?
Session
Cooling the fire of cardiovascular inflammation: what are the treatment options in 2026?
28 August 2026
Imaging or biomarkers: which is superior in risk prediction?
Session
Imaging or biomarkers: which is superior in risk prediction?
26 August 2023
How to deal with residual cardiovascular risk in atherosclerotic disease? New pharmacotherapeutic options
Session
How to deal with residual cardiovascular risk in atherosclerotic disease? New pharmacotherapeutic options
29 August 2022
Prevention of cardiovascular diseases in the post-COVID19 era
Session
Prevention of cardiovascular diseases in the post-COVID19 era
28 August 2022
Cardiac biomarkers for atherosclerotic cardiovascular disease risk prediction
Session
Cardiac biomarkers for atherosclerotic cardiovascular disease risk prediction
30 August 2021